Anti-ErbB-3 (Her-3) antibodies, human

Anti-ErbB-3 (Her-3) antibodies, human

Clone: REA508 | Dilution: 1:11
Clone REA508 recognizes the human ErbB-3 antigen, a single-pass type I membrane protein, which is also known as tyrosine kinase-type cell surface receptor HER3. ErbB-3 is a receptor tyrosine kinase and a member of the epidermal growth factor receptor family (EGFR). It is unique among the ErbB family members in that it is has been shown to have weak or no tyrosine kinase activity. After dimerization with other members of the EGFR family several signal transduction cascades can be activated, including phosphoinosite 3'-kinase (PI3-K)/Akt and extracellular signal-regulated kinase (ERK1/2). ErbB-3 is widely expressed in normal tissues including cells of the gastrointestinal, reproductive, respiratory and urinary tracts, as well as the skin, endocrine, and nervous system. It is expressed at elevated levels in a range of human malignancies.
Additional information: Clone REA508 displays negligible binding to Fc receptors.

Alternative names

ErbB3, HER3, LCCS2, MDA-BF-1, c-ErbB-3, erbB3-S

Technical specifications

  • Antigen: ErbB-3 (Her-3)
  • Clone: REA508
  • Isotype: recombinant human IgG1
  • Isotype control: REA Control (S) antibodies
  • Alternative names of antigen: ErbB3, HER3, LCCS2, MDA-BF-1, c-ErbB-3, erbB3-S
  • Entrez Gene ID: 2065
  • Molecular mass of antigen [kDa]: 146
  • Distribution of antigen: ubiquitous
  • Product format: Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
  • Fixation: Cells should be stained prior to fixation, if formaldehyde is used as a fixative.
  • Storage: Store protected from light at 2–8 °C. Do not freeze.
  • Available conjugates: VioBright FITC, PE, APC, PE-Vio770, APC-Vio770, Biotin
  • Selected references

    1. Kraus, M. H. et al. (1989) Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. U.S.A. 86(23): 9193-9197
    2. Citri, A. et al. (2003) The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp. Cell Res. 284(1): 54-65
    3. Ghasemi, R. et al. (2014) Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. Oncogenesis 3: 117
Product options: 12
130-107-965

Anti-ErbB-3 (Her-3)-VioBright FITC, human

for 30
tests
(1)
DKK 1.000,00 
130-107-903

Anti-ErbB-3 (Her-3)-VioBright FITC, human

for 100
tests
(1)
DKK 2.400,00 
130-107-961

Anti-ErbB-3 (Her-3)-PE, human

for 30
tests
(1)
DKK 900,00 
130-107-899

Anti-ErbB-3 (Her-3)-PE, human

for 100
tests
(1)
DKK 2.200,00 
130-107-962

Anti-ErbB-3 (Her-3)-APC, human

for 30
tests
(1)
DKK 900,00 
130-107-900

Anti-ErbB-3 (Her-3)-APC, human

for 100
tests
(1)
DKK 2.200,00 
130-107-963

Anti-ErbB-3 (Her-3)-PE-Vio770, human

for 30
tests
(1)
DKK 1.000,00 
130-107-901

Anti-ErbB-3 (Her-3)-PE-Vio770, human

for 100
tests
(1)
DKK 2.400,00 
130-107-964

Anti-ErbB-3 (Her-3)-APC-Vio770, human

for 30
tests
(1)
DKK 1.000,00 
130-107-902

Anti-ErbB-3 (Her-3)-APC-Vio770, human

for 100
tests
(1)
DKK 2.400,00 
130-107-960

Anti-ErbB-3 (Her-3)-Biotin, human

for 30
tests
(1)
DKK 750,00 
130-107-898

Anti-ErbB-3 (Her-3)-Biotin, human

for 100
tests
(1)
DKK 1.850,00